SACGHS Misses Opportunity for Sound Gene-Patenting Advice

The panel's recommendations, handed up one day after gene patents begin their defense in another arena, is noteworthy not only for the threat to patient care it would engender, but for the cavalier way in which their authors support their decision.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.